Igietseme J - Search Results

1

Evaluation of a Single Dose of Azithromycin for Trachoma in Low-Prevalence Communities.

Wilson N, Goodhew B, Mkocha H, Joseph K, Bandea C, Black C, Igietseme J, Munoz B, West SK, Lammie P, Kasubi M, Martin DL. Wilson N, et al. Among authors: igietseme j. Ophthalmic Epidemiol. 2019 Feb;26(1):1-6. doi: 10.1080/09286586.2017.1293693. Epub 2018 Dec 13. Ophthalmic Epidemiol. 2019. PMID: 30543311 Free PMC article. Clinical Trial.

2

Immune control of Chlamydial growth in the human epithelial cell line RT4 involves multiple mechanisms that include nitric oxide induction, tryptophan catabolism and iron deprivation.

Igietseme JU, Ananaba GA, Candal DH, Lyn D, Black CM. Igietseme JU, et al. Microbiol Immunol. 1998;42(9):617-25. doi: 10.1111/j.1348-0421.1998.tb02332.x. Microbiol Immunol. 1998. PMID: 9802562 Free article.

3

The intercellular adhesion molecule type-1 is required for rapid activation of T helper type 1 lymphocytes that control early acute phase of genital chlamydial infection in mice.

Igietseme JU, Ananaba GA, Bolier J, Bowers S, Moore T, Belay T, Lyn D, Black CM. Igietseme JU, et al. Immunology. 1999 Dec;98(4):510-9. doi: 10.1046/j.1365-2567.1999.00926.x. Immunology. 1999. PMID: 10594682 Free PMC article.

4

Suppression of endogenous IL-10 gene expression in dendritic cells enhances antigen presentation for specific Th1 induction: potential for cellular vaccine development.

Igietseme JU, Ananaba GA, Bolier J, Bowers S, Moore T, Belay T, Eko FO, Lyn D, Black CM. Igietseme JU, et al. J Immunol. 2000 Apr 15;164(8):4212-9. doi: 10.4049/jimmunol.164.8.4212. J Immunol. 2000. PMID: 10754317

5

Chlamydia vaccines: strategies and status.

Igietseme JU, Black CM, Caldwell HD. Igietseme JU, et al. BioDrugs. 2002;16(1):19-35. doi: 10.2165/00063030-200216010-00003. BioDrugs. 2002. PMID: 11908999 Review.

6

Recombinant Vibrio cholerae ghosts as a delivery vehicle for vaccinating against Chlamydia trachomatis.

Eko FO, Lubitz W, McMillan L, Ramey K, Moore TT, Ananaba GA, Lyn D, Black CM, Igietseme JU. Eko FO, et al. Vaccine. 2003 Apr 2;21(15):1694-703. doi: 10.1016/s0264-410x(02)00677-1. Vaccine. 2003. PMID: 12639492

7

Contemporary approaches to designing and evaluating vaccines against Chlamydia.

Igietseme JU, Eko FO, Black CM. Igietseme JU, et al. Expert Rev Vaccines. 2003 Feb;2(1):129-46. doi: 10.1586/14760584.2.1.129. Expert Rev Vaccines. 2003. PMID: 12901604 Review.

8

Antibody regulation of Tcell immunity: implications for vaccine strategies against intracellular pathogens.

Igietseme JU, Eko FO, He Q, Black CM. Igietseme JU, et al. Expert Rev Vaccines. 2004 Feb;3(1):23-34. doi: 10.1586/14760584.3.1.23. Expert Rev Vaccines. 2004. PMID: 14761241 Review.

9

Developing effective delivery systems for Chlamydia vaccines.

Igietseme JU, Eko FO, He Q, Bandea C, Black CM. Igietseme JU, et al. Curr Opin Mol Ther. 2004 Apr;6(2):182-94. Curr Opin Mol Ther. 2004. PMID: 15195931

10

A novel recombinant multisubunit vaccine against Chlamydia.

Eko FO, He Q, Brown T, McMillan L, Ifere GO, Ananaba GA, Lyn D, Lubitz W, Kellar KL, Black CM, Igietseme JU. Eko FO, et al. J Immunol. 2004 Sep 1;173(5):3375-82. doi: 10.4049/jimmunol.173.5.3375. J Immunol. 2004. PMID: 15322201

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

93 results

Search Page